A study published in the New England Journal of Medicine Wednesday suggests full doses of the blood thinner heparin improved outcomes and decreased the need for life-support for moderately ill COVID-19 patients.
from CBC | Health News https://ift.tt/3A5U0Lq
Aucun commentaire:
Enregistrer un commentaire